Primary Balloon Angioplasty Versus Conventional Dilatation During Arteriovenous Fistula Procedure In ESRD Patients With Small Vein Diameter

Objective: The purpose of this research is to determine whether intraoperative primary balloon angioplasty (PBA) is a useful tool for expanding small-caliber veins before an AVF can be built. Patients and methods: This investigation was designed as a single-center randomized-controlled trial. Participating patients had end-stage renal disease (ESRD), a small vein diameter (≤ 2.5 mm), and were advised to undergo AVF creation. One group, the Primary Balloon Angioplasty (PBA) group, underwent the insertion of a 0.018-inch guidewire through the cephalic or basilic veins under fluoroscopic guidance. A noncompliant balloon was then advanced over the guidewire and gently inflated to reach a final diameter of 4 mm. These veins were dilated in the second group (Hydrostatic Dilatation (HD) group) using a high-pressure sterile saline solution. After that, both groups had an end-to-side anastomosis using 6/0 polypropylene running sutures. Results: 40 patients were eligible to participate between January 2023 and September 2024, and they were divided into two groups. There was an instantaneous success rate of 100% in the PBA group and 80% in the HD group. The main patency rate at six months was 95% in the PBA group and 67% in the HD group (P = 0.038). The first puncture time in the PBA group was 29.7±4.86 days (range: 21-39 days), whereas in the HD group it was 49.35±4.32 days (range: 41-56 days) (P <0.001). This difference was statistically significant. A functional AVF was achieved by twenty patients (100%) in the PBA group and nineteen patients (90%) in the HD group (P = 0.5). Conclusion: For AVF treatments, primary balloon angioplasty (PBA) seems to be efficient and more successful than hydrostatic dilatation (HD). It offers greater long-term patency, lower complication rates, higher immediate success rates, and less time for use. It requires supplementary therapy and has a longer process time.

Institutions

Publication Details

Journal
International Journal of Medical Arts
Published
2025-12-18
DOI
https://doi.org/10.21608/ijma.2025.426541.2296
Primary Topic
Central Venous Catheters and Hemodialysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Primary Balloon Angioplasty Versus Conventional Dilatation During Arteriovenous Fistula Procedure In ESRD Patients With Small Vein Diameter

International Journal of Medical Arts
Central Venous Catheters and Hemodialysis
article

Primary Balloon Angioplasty Versus Conventional Dilatation During Arteriovenous Fistula Procedure In ESRD Patients With Small Vein Diameter

article en

Abstract

Objective: The purpose of this research is to determine whether intraoperative primary balloon angioplasty (PBA) is a useful tool for expanding small-caliber veins before an AVF can be built. Patients and methods: This investigation was designed as a single-center randomized-controlled trial. Participating patients had end-stage renal disease (ESRD), a small vein diameter (≤ 2.5 mm), and were advised to undergo AVF creation. One group, the Primary Balloon Angioplasty (PBA) group, underwent the insertion of a 0.018-inch guidewire through the cephalic or basilic veins under fluoroscopic guidance. A noncompliant balloon was then advanced over the guidewire and gently inflated to reach a final diameter of 4 mm. These veins were dilated in the second group (Hydrostatic Dilatation (HD) group) using a high-pressure sterile saline solution. After that, both groups had an end-to-side anastomosis using 6/0 polypropylene running sutures. Results: 40 patients were eligible to participate between January 2023 and September 2024, and they were divided into two groups. There was an instantaneous success rate of 100% in the PBA group and 80% in the HD group. The main patency rate at six months was 95% in the PBA group and 67% in the HD group (P = 0.038). The first puncture time in the PBA group was 29.7±4.86 days (range: 21-39 days), whereas in the HD group it was 49.35±4.32 days (range: 41-56 days) (P <0.001). This difference was statistically significant. A functional AVF was achieved by twenty patients (100%) in the PBA group and nineteen patients (90%) in the HD group (P = 0.5). Conclusion: For AVF treatments, primary balloon angioplasty (PBA) seems to be efficient and more successful than hydrostatic dilatation (HD). It offers greater long-term patency, lower complication rates, higher immediate success rates, and less time for use. It requires supplementary therapy and has a longer process time.

International Journal of Medical ArtsVol. 0(0)
Shebin Teaching Hospital (EG), Menoufia University (EG)
Openalex Percentile: Top 41%
Central Venous Catheters and Hemodialysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.